Neuberger Berman Group
CLCD

Neuberger Berman Group’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Neuberger Berman Group’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-12,000
Closed -$437K – 1693
2016
Q4 		$437K Hold
12,000
– – ﹤0.01% 1316
2016
Q3 		$458K Buy
+12,000
New +$177K ﹤0.01% 1289

Other funds holding CLCD

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Neuberger Berman Group's CLCD Position: Q1 2017 in Review

Neuberger Berman Group sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 12,000 shares — an estimated $437K sold.

Neuberger Berman Group first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $458K in Q3 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

  • Neuberger Berman Group reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Neuberger Berman Group sold 12,000 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $437K.
  • Neuberger Berman Group first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
  • Neuberger Berman Group's CoLucid Pharmaceuticals, Inc. position peaked at $458K in Q3 2016.
  • 1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Neuberger Berman Group's 13F filing for Q1 2017, filed 10 May 2017.